Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Total Liabilities 2009–2025
Pacific Biosciences of California, Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Pacific Biosciences of California, Inc. total liabilities as of December 31, 2025: 778.7M, a 3.30% increase year-over-year.
- Pacific Biosciences of California, Inc. total liabilities for 2025 were 778.7M, a 3.30% increase from 2024.
- Pacific Biosciences of California, Inc. total liabilities for 2024 were 753.9M, a 27.84% decrease from 2023.
- Pacific Biosciences of California, Inc. total liabilities for 2023 were 1.04B, a 13.24% decrease from 2022.
- Pacific Biosciences of California, Inc. total liabilities for 2022 were 1.20B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pacific Biosciences of California, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $779 |
| 2024 | $754 |
| 2023 | $1,045 |
| 2022 | $1,204 |
| 2021 | $1,216 |
| 2020 | $78 |
| 2019 | $93 |
| 2018 | $56 |
| 2017 | $58 |
| 2016 | $53 |
| 2015 | $58 |
| 2014 | $69 |
| 2013 | $67 |
| 2012 | $20 |
| 2011 | $27 |
Pacific Biosciences of California, Inc. Total Liabilities — FAQ
Pacific Biosciences of California, Inc. (PACB) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's total liabilities history?
The chart and table above show Pacific Biosciences of California, Inc.'s total liabilities by year and by quarter, including the growth rate.